We are live on !
Find out more
BB&T Securities Portfolio holdings
AUM
$10.9B
Turnover
12.04%
1-Year Est. Return
5.31%
This Fund
S&P 500
This Quarter Est. Return
+2.34%
1 Year Est. Return
+5.31%
3 Year Est. Return
+33.1%
5 Year Est. Return
+46.68%
10 Year Est. Return
–
AUM
$6.9B
AUM Growth
-$437M
(-6%)
Cap. Flow
-$575M
Cap. Flow % of AUM
Cap. Flow %
-8.34%
Top 10 Holdings %
Top 10 Hldgs %
10.73%
Holding
1,452
New
223
Increased
772
Reduced
351
Closed
72
Avg Time Held
Equity + Options
2.1
years
Top 10 Avg Time Held
Equity + Options
0.9
years
Top 20 Avg Time Held
Equity + Options
1.4
years
Avg Time Held Equity only
2.1
years
Top 10 Avg Time Held Equity only
0.9
years
Top 20 Avg Time Held Equity only
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$28.5M |
| 2 |
JPMorgan Chase
JPM
|
+$24.6M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$22.1M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$19.3M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$18.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$41.1M |
| 2 |
General Motors
GM
|
+$38.6M |
| 3 |
Honeywell
HON
|
+$38.5M |
| 4 |
Abbott
ABT
|
+$32.3M |
| 5 |
Comcast
CMCSA
|
+$32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 28.76% |
| 2 | Healthcare | 12.97% |
| 3 | Financials | 9.78% |
| 4 | Industrials | 9.66% |
| 5 | Technology | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1326
Voya Global Advantage and Premium Opportunity Fund
IGA
$156M
| $139K | ﹤0.01% |
+12,903
| New | +$137K |
2017 Q2
0 quarters
|
|
|
GG
1327
DELISTED
Goldcorp Inc
GG
| $139K | ﹤0.01% |
10,783
-242
| -2% | -$3.39K |
2017 Q1
1 quarter
|
|
1328
Nuveen Floating Rate Income Fund
JFR
$1.17B
| $138K | ﹤0.01% |
+11,708
| New | +$138K |
2017 Q2
0 quarters
|
|
1329
Vipshop
VIPS
$6.11B
| $138K | ﹤0.01% |
+13,141
| New | +$172K |
2017 Q2
0 quarters
|
|
1330
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.02B
| $137K | ﹤0.01% |
12,120
-6,730
| -36% | -$76.3K |
2015 Q1
9 quarters
|
|
1331
Opko Health
OPK
$1.14B
| $135K | ﹤0.01% |
20,600
+1,460
| +8% | +$10.2K |
2017 Q1
1 quarter
|
|
1332
Flagstar Bank National Association
FLG
$4.6B
| $135K | ﹤0.01% |
+3,452
| New | +$137K |
2017 Q2
0 quarters
|
|
1333
Western Asset High Income Opportunity Fund
HIO
$313M
| $133K | ﹤0.01% |
26,412
-9,000
| -25% | -$46.4K |
2016 Q1
5 quarters
|
|
1334
Templeton Emerging Markets Income Fund
TEI
$293M
| $132K | ﹤0.01% |
+11,777
| New | +$134K |
2017 Q2
0 quarters
|
|
|
FMSA
1335
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
| $132K | ﹤0.01% |
33,900
+23,200
| +217% | +$120K |
2017 Q1
1 quarter
|
|
1336
DELISTED
Gannett Co., Inc
GCI
| $129K | ﹤0.01% |
+14,834
| New | +$123K |
2017 Q2
0 quarters
|
|
|
MVC
1337
DELISTED
MVC Capital, Inc.
MVC
| $124K | ﹤0.01% |
12,638
+1,429
| +13% | +$13.1K |
2013 Q2
16 quarters
|
|
1338
Calamos Convertible and High Income Fund
CHY
$894M
| $118K | ﹤0.01% |
10,024
-4,266
| -30% | -$49.6K |
2015 Q3
7 quarters
|
|
1339
Celldex Therapeutics
CLDX
$2.16B
| $117K | ﹤0.01% |
+3,177
| New | +$141K |
2017 Q2
0 quarters
|
|
1340
PhenixFIN
PFX
$85.1M
| $112K | ﹤0.01% |
+876
| New | +$119K |
2017 Q2
0 quarters
|
|
1341
Alaunos Therapeutics
TCRT
$6.68M
| $112K | ﹤0.01% |
+120
| New | +$118K |
2017 Q2
0 quarters
|
|
|
JMLP
1342
DELISTED
NUVEEN ALL CAP ENERGY MLP OPPORTUNITIES FUND
JMLP
| $107K | ﹤0.01% |
+11,600
| New | +$114K |
2017 Q2
0 quarters
|
|
|
JCO
1343
DELISTED
Nuveen Credit Opportunities 2022 Target Term Fund
JCO
| $106K | ﹤0.01% |
+10,600
| New | +$107K |
2017 Q2
0 quarters
|
|
|
IGR
1344
CBRE Global Real Estate Income Fund
IGR
$564M
| $99K | ﹤0.01% |
+4,300
| New | +$98.4K |
2017 Q2
0 quarters
|
|
1345
Calamos Global Dynamic Income Fund
CHW
$497M
| $98K | ﹤0.01% |
11,535
-2,005
| -15% | -$16.6K |
2013 Q2
16 quarters
|
|
1346
PIMCO High Income Fund
PHK
$762M
| $96K | ﹤0.01% |
+10,988
| New | +$96.1K |
2017 Q2
0 quarters
|
|
1347
Gladstone Investment Corp
GAIN
$599M
| $95K | ﹤0.01% |
+10,118
| New | +$94.2K |
2017 Q2
0 quarters
|
|
1348
MidCap Financial Investment
MFIC
$687M
| $94K | ﹤0.01% |
+4,930
| New | +$95.9K |
2017 Q2
0 quarters
|
|
|
RAD
1349
DELISTED
Rite Aid Corporation
RAD
| $92K | ﹤0.01% |
1,564
| – | – |
2013 Q4
14 quarters
|
|
1350
Constellium
CSTM
$3.45B
| $91K | ﹤0.01% |
+13,250
| New | +$86.3K |
2017 Q2
0 quarters
|
|
Similar funds
MCIM
GHCM
EP
FCM
NA
TAM
BB&T Securities's Q2 2017 Portfolio in Review
As of Q2 2017, BB&T Securities held 1,452 positions worth $6.9B, down 6% from $7.33B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
BB&T Securities withdrew a net $575M in Q2 2017, closing 72 positions and reducing 351 holdings. Its most notable exit was POWERSHARES DYNAMIC MID CAP VALUE PORTFOLIO, an estimated $10.5M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, BB&T Securities opened a new position in First Trust Nasdaq-100 Select Equal Weight ETF worth $12.2M.
- BB&T Securities's largest Q2 2017 buy was First Trust Nasdaq-100 Select Equal Weight ETF: 227,560 shares worth $12.2M.
- BB&T Securities added most to iShares Core MSCI EAFE ETF in Q2 2017, an estimated $28.5M increase.
- BB&T Securities's biggest Q2 2017 reduction was Elevance Health, cutting an estimated $41.1M.
- BB&T Securities fully exited POWERSHARES DYNAMIC MID CAP VALUE PORTFOLIO in Q2 2017, selling an estimated $10.5M.
- BB&T Securities's ten largest holdings make up 11% of its $6.9B portfolio in Q2 2017.
- BB&T Securities opened 223 new positions and closed 72 in Q2 2017.
- BB&T Securities's portfolio value fell 6% quarter-over-quarter to $6.9B.
Based on BB&T Securities's 13F filing for Q2 2017, filed 4 Aug 2017.